Overview

A Study to Evaluate the Effectiveness and Safety of OZURDEX® in Patients With Diabetic Macular Edema But Never Treated

Status:
Active, not recruiting

Trial end date:
2022-08-30

Target enrollment:

Participant gender:

Summary

This study will evaluate the efficacy and safety of OZURDEX in patients with Diabetic Macular Edema when used in a real world setting in Spain and Portugal.

Phase:

Phase 4

Details

Lead Sponsor:

Allergan

Treatments:

BB 1101
Dexamethasone
Dexamethasone acetate